Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mami Kasahara-Kiritani

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Therapeutic Advances in Hematology|February 26, 2026
A retrospective real-world study assessing diagnostic pattern of light-chain amyloidosis in Japan based on data from the medical data vision claims databaseMoe Yogo, Mami Kasahara-Kiritani, Kazuki Oshima, et al.
Death Studies|March 28, 2017
Regaining my new life: Daily lives of suicide-bereaved individualsMami Kasahara-Kiritani, Mari Ikeda, Noriko Yamamoto-Mitani, et al.
Advances in Therapy|August 12, 2023
Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based ChemotherapyHidetoshi Hayashi, Makoto Nishio, Michiko Takahashi, et al.
Journal of Medical Economics|April 10, 2020
Budget impact analysis of long acting injection for schizophrenia in JapanMami Kasahara-Kiritani, Amish Chaturvedi, Ataru Inagaki, et al.
Social Science & Medicine (1982)|April 5, 2019
Mental health care and the cultural toolboxes of the present-day Japanese population: Examining suggested patterns of care and their correlatesSaeko Kikuzawa, Bernice Pescosolido, Mami Kasahara-Kiritani, et al.
Asian Journal of Psychiatry|June 13, 2023
Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: A real-world study in JapanMami Kasahara-Kiritani, Yosuke Saga, Akihide Wakamatsu, et al.
BMC Psychiatry|July 2, 2025
Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients' and physicians' perspectivesMami Kasahara-Kiritani, Tadafumi Kato, Akihide Wakamatsu, et al.
Asian Journal of Psychiatry|May 23, 2018
Public perceptions toward mental illness in JapanMami Kasahara-Kiritani, Tomoko Matoba, Saeko Kikuzawa, et al.
Cancer Medicine|January 10, 2024
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancerAkito Hata, Simon Fifer, Kazuo Hasegawa, et al.
Asian Journal of Psychiatry|March 26, 2025
Budget impact analysis of long-acting injections for the treatment of Schizophrenia in JapanMami Kasahara-Kiritani, Chu-Chu Sheng, Nan Li, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Therapeutic Advances in Hematology|February 26, 2026
A retrospective real-world study assessing diagnostic pattern of light-chain amyloidosis in Japan based on data from the medical data vision claims databaseMoe Yogo, Mami Kasahara-Kiritani, Kazuki Oshima, et al.
Death Studies|March 28, 2017
Regaining my new life: Daily lives of suicide-bereaved individualsMami Kasahara-Kiritani, Mari Ikeda, Noriko Yamamoto-Mitani, et al.
Advances in Therapy|August 12, 2023
Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based ChemotherapyHidetoshi Hayashi, Makoto Nishio, Michiko Takahashi, et al.
Journal of Medical Economics|April 10, 2020
Budget impact analysis of long acting injection for schizophrenia in JapanMami Kasahara-Kiritani, Amish Chaturvedi, Ataru Inagaki, et al.
Social Science & Medicine (1982)|April 5, 2019
Mental health care and the cultural toolboxes of the present-day Japanese population: Examining suggested patterns of care and their correlatesSaeko Kikuzawa, Bernice Pescosolido, Mami Kasahara-Kiritani, et al.
Asian Journal of Psychiatry|June 13, 2023
Clinical benefit of second-generation long-acting injectable antipsychotics in preventing re-hospitalization in patients with schizophrenia: A real-world study in JapanMami Kasahara-Kiritani, Yosuke Saga, Akihide Wakamatsu, et al.
BMC Psychiatry|July 2, 2025
Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients' and physicians' perspectivesMami Kasahara-Kiritani, Tadafumi Kato, Akihide Wakamatsu, et al.
Asian Journal of Psychiatry|May 23, 2018
Public perceptions toward mental illness in JapanMami Kasahara-Kiritani, Tomoko Matoba, Saeko Kikuzawa, et al.
Cancer Medicine|January 10, 2024
Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor-mutant non-small cell lung cancerAkito Hata, Simon Fifer, Kazuo Hasegawa, et al.
Asian Journal of Psychiatry|March 26, 2025
Budget impact analysis of long-acting injections for the treatment of Schizophrenia in JapanMami Kasahara-Kiritani, Chu-Chu Sheng, Nan Li, et al.
Pageof 2